China’s Respiratory Sector Luring Multinationals
This article was originally published in PharmAsia News
Executive Summary
China has about 30 million people suffering from asthma, and just over 8% of the population aged above 40 has chronic obstructive pulmonary disease (COPD), compared with 3% in neighboring India, Chinese authorities said at a forum on innovative drug delivery technology held earlier this year in Suzhou.